sitagliptin + atorvastatin (MK-0431E) - Merck (MSD)
(-) Merck & Co stops development of Januvia, atorvastatin combo (PMLive) - Nov 13, 2012 - Merck discontinued development of MK-0431E (sitagliptin and atorvastatin) which had been scheduled for regulatory filings in 2014 
Discontinued • Diabetes
http://www.pmlive.com/news/research/2012/november/merck_and_co_stops_development_of_januvia,_atorvastatin_combo_450074
 
Nov 13, 2012
 
.